華鵬飛(300350.SZ)：控股子公司取得第二類醫療器械經營備案憑證
格隆匯3月24日丨華鵬飛(300350.SZ)公佈，公司控股子公司深圳市華鵬飛供應鏈管理有限公司(“華鵬飛供應鏈”)於2020年3月23日取得深圳市市場監督管理局頒發的第二類醫療器械經營備案憑證，備案編號為：粵深食藥監械經營備202040990號。
經營範圍：2002年分類目錄(二類)：6801基礎外科手術器械；6802顯微外科手術器械；6803神經外科手術器械；6804眼科手術器械；6805耳鼻喉科手術器械；6806口腔科手術器械；6807胸腔心血管外科手術器械；6808腹部外科手術器械；6809泌尿肛腸外科手術器械；6810矯形外科(骨科)手術器械；6812婦產科用手術器械；6813計劃生育手術器械；6815注射穿刺器械；6816燒傷(整形)科手術器械；6820普通診察器械；6821醫用電子儀器設備；6822醫用光學器具、儀器及內窺鏡設備；6823醫用超聲儀器及有關設備；6824醫用激光儀器設備；6825醫用高頻儀器設備；6826物理治療及康復設備；6827中醫器械；6828醫用磁共振設備；6830醫用X射線設備；6831醫用X射線附屬設備及部件；6832醫用高能射線設備；6833醫用核素設備；6834醫用射線防護用品、裝置；6840臨牀檢驗分析儀器(體外診斷試劑除外)；6841醫用化驗和基礎設備器具；6845體外循環及血液處理設備；6846植入材料和人工器官；6854手術室、急救室、診療室設備及器具；6855口腔科設備及器具；6856病房護理設備及器具；6857消毒和滅菌設備及器具；6858醫用冷療、低温、冷藏設備及器具；6863口腔科材料；6864醫用衞生材料及敷料；6865醫用縫合材料及粘合劑；6866醫用高分子材料及製品；6870軟件；6877介入器材，以上類別包含的植入和介入類產品除外，以上類別中包含的角膜接觸鏡、助聽器產品除外；2017年分類目錄(二類)：01有源手術器械；02無源手術器械；03神經和心血管手術器械；04骨科手術器械；05放射治療器械；06醫用成像器械；07醫用診察和監護器械；08呼吸、麻醉和急救器械；09物理治療器械；10輸血、透析和體外循環器械；11醫療器械消毒滅菌器械；12有源植入器械；13無源植入器械；14注輸、護理和防護器械；15患者承載器械；16眼科器械；17口腔科器械；18婦產科、輔助生殖和避孕器械；19醫用康復器械；20中醫器械；21醫用軟件；22臨牀檢驗器械，以上類別包含的植入和介入類產品除外，以上類別中包含的角膜接觸鏡、助聽器產品除外。
華鵬飛供應鏈此次依法辦理第二類醫療器械經營備案是基於當前國內外新型冠狀病毒肺炎疫情蔓延，相關醫療防疫物資存在缺口，基於公司目前服務客户的要求及公司新增業務需求，此次增加第二類醫療器械產品的經營範圍備案。華鵬飛供應鏈新增第二類醫療器械經營備案有助於其開展第二類醫療器械產品的進出口業務，提升客户服務能力，公司將按照相關法規及政策文件並結合實際情況合法合規開展相關業務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
